Literature DB >> 11122762

Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.

J Plutzky1.   

Abstract

Peroxisome Proliferator-Activated Receptors (PPARs), members of the steroid hormone nuclear receptor superfamily, act as ligand-activated transcription factors controlling the expression of specific target genes. Known PPAR isoforms include PPAR gamma, important in adipogenesis and lipid metabolism, PPAR alpha, implicated in fatty acid metabolism, and PPAR delta, about which the least is known. Recent work implicates PPAR alpha and gamma in vascular biology and atherosclerosis, and will be reviewed here. Such effects may have clinical implications given PPAR agonists in use as pharmacologic agents (eg, thiazolidinediones as insulin sensitizers [gamma] and fibric acids as lipid lowering agents [alpha]).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122762     DOI: 10.1007/s11883-000-0067-3

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  103 in total

Review 1.  The PPARs: from orphan receptors to drug discovery.

Authors:  T M Willson; P J Brown; D D Sternbach; B R Henke
Journal:  J Med Chem       Date:  2000-02-24       Impact factor: 7.446

Review 2.  Transcription-modulating drugs: a new frontier in the treatment of essential hypertension.

Authors:  T W Kurtz; D G Gardner
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190

3.  A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans.

Authors:  A Meirhaeghe; L Fajas; N Helbecque; D Cottel; P Lebel; J Dallongeville; S Deeb; J Auwerx; P Amouyel
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

Review 4.  Thiazolidinediones in the treatment of insulin resistance and type II diabetes.

Authors:  A R Saltiel; J M Olefsky
Journal:  Diabetes       Date:  1996-12       Impact factor: 9.461

Review 5.  Matrix metalloproteinases and cardiovascular disease.

Authors:  C M Dollery; J R McEwan; A M Henney
Journal:  Circ Res       Date:  1995-11       Impact factor: 17.367

6.  Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease.

Authors:  X L Wang; J Oosterhof; N Duarte
Journal:  Cardiovasc Res       Date:  1999-12       Impact factor: 10.787

7.  Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

Authors:  H Satoh; K Tsukamoto; Y Hashimoto; N Hashimoto; M Togo; M Hara; H Maekawa; N Isoo; S Kimura; T Watanabe
Journal:  Biochem Biophys Res Commun       Date:  1999-01-27       Impact factor: 3.575

8.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

Review 9.  Fatty acid activation of the peroxisome proliferator activated receptor, a member of the nuclear receptor gene superfamily.

Authors:  K L Gearing; M Göttlicher; E Widmark; C D Banner; P Tollet; M Strömstedt; J J Rafter; R K Berge; J A Gustafsson
Journal:  J Nutr       Date:  1994-08       Impact factor: 4.798

10.  Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.

Authors:  N Vu-Dac; K Schoonjans; V Kosykh; J Dallongeville; J C Fruchart; B Staels; J Auwerx
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more
  23 in total

1.  Genetics and molecular biology: a role for adipocyte lipid-binding protein in atherosclerosis.

Authors:  Jheem D Medh
Journal:  Curr Opin Lipidol       Date:  2002-02       Impact factor: 4.776

2.  4',6-Dimethoxyisoflavone-7-O-β-D-glucopyranoside (wistin) is a peroxisome proliferator-activated receptor α (PPARα) agonist in mouse hepatocytes.

Authors:  Misato Suzuki; Fumiya Nakamura; Emi Taguchi; Maho Nakata; Fumi Wada; Momoka Takihi; Tomoyo Inoue; Shinji Ohta; Hiroyuki Kawachi
Journal:  Mol Cell Biochem       Date:  2018-01-09       Impact factor: 3.396

3.  High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion.

Authors:  Waleed Ahmed; Gabriela Orasanu; Vedika Nehra; Liana Asatryan; Daniel J Rader; Ouliana Ziouzenkova; Jorge Plutzky
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

4.  The effects of PPARγ on the regulation of the TOMM40-APOE-C1 genes cluster.

Authors:  Shobana Subramanian; William K Gottschalk; So Young Kim; Allen D Roses; Ornit Chiba-Falek
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-06       Impact factor: 5.187

Review 5.  Vascular signaling pathways in the metabolic syndrome.

Authors:  Hiromi Rakugi; Kei Kamide; Toshio Ogihara
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

6.  Hypochlorite-oxidized low-density lipoprotein upregulates CD36 and PPARgamma mRNA expression and modulates SR-BI gene expression in murine macrophages.

Authors:  Thomas Westendorf; Juergen Graessler; Steffi Kopprasch
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

Review 7.  Peroxisome proliferator-activated receptor alpha and hypertensive heart disease.

Authors:  Maria J Goikoetxea; Javier Beaumont; Javier Díez
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ.

Authors:  Lu Han; Wen-Jun Shen; Stefanie Bittner; Fredric B Kraemer; Salman Azhar
Journal:  Future Cardiol       Date:  2017-06-05

Review 9.  PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.

Authors:  Lu Han; Wen-Jun Shen; Stefanie Bittner; Fredric B Kraemer; Salman Azhar
Journal:  Future Cardiol       Date:  2017-06-05

10.  The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis.

Authors:  Wenjun Xu; Jiahong Xu; Bing Sun; Haibin Chen; Yiping Wang; Feifei Huang; Peng Xi; Jinfa Jiang
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.